Monz takes over as ceo of Carl Zeiss Meditec
Ludwin Monz has been named as chief executive of Carl Zeiss Meditec.
Monz has been a member of Carl Zeiss Meditec's management board since October 2007 and is responsible for the firm's Ophthalmological Systems division. Prior to this he led the Microsurgery division for six years.
With a doctorate in physics and an MBA, Monz joined the Carl Zeiss Group in 1994 and has worked in medical technology since 2000.
You may also like
You need to be a subscriber to read this article.
Click here to find out more.
Click here to find out more.
Regulatory
Right-sized, not oversized: rethinking quality management technology for the UK's growing manufacturers (part II)
How the enterprise trap is set: familiar platforms, borrowed requirements and hidden validation costs can turn seemingly safe purchasing decisions into costly operational burdens
You need to be a subscriber to read this article.
Click here to find out more.
Click here to find out more.
Digital
Right-sized, not oversized: rethinking quality management technology for the UK's growing manufacturers (part I)
As the UK builds its own standalone device framework alongside continuing EU obligations, Mike King argues that manufacturers need quality management technology built for flexibility … not for the scale of the industry's largest players
You need to be a subscriber to read this article.
Click here to find out more.
Click here to find out more.
Digital
Abolis launches microbial intelligence platform to optimise bioprocess development
The company has launched MINE, a multi-omics platform designed to help pharmaceutical and other industrial R&D teams identify microbial production pathways, prioritise experiments and support fermentation process optimisation and scale-up
Digital
Charles River and Autolomous launch Apollo Orchestrate LES to digitalise biologics QC testing workflow
The autoloMATE-powered platform connects sample submission, laboratory execution and review into a single digital workflow across Charles River's North American and European Biologics Testing Solutions sites — replacing paper-based processes to accelerate client results
You need to be a subscriber to read this article.
Click here to find out more.
Click here to find out more.